Abstract
Hepatic fibrosis represents the main complication of most chronic liver disorders and, regardless of its etiology, is characterized by excessive deposition of extracellular matrix components. In this study, we examined that 1-O-Hexyl-2,3,5-Trimethylhydroquinone (HTHQ), a potent anti-oxidative agent, could prevent experimental hepatic fibrosis induced by dimethylnitrosamine (DMN) in male SD rats. Except for vehicle control group, other groups were induced hepatic fibrosis by intraperitoneal injection with DMN (10 mg/ m//kg) on 3 consecutive days weekly for 4 weeks. During the same 4 weeks, control and DMN groups were given vehicle and HTHQ 50, 100 and 200 groups were orally administered HTHQ (50, 100, 200 mg/ kg respectively). In HTHQ 100 and 200 groups, relative liver weight and serum chemistry level improved significantly. HTHQ reduced hydroxyproline (p < 0.05) and malondialdehyde (p < 0.05) level in the liver. Histopathological examination of H&E, Masson’s trichrome stain showed the reduced fibrotic septa in HTHQ 100 and 200 groups. HTHQ administration showed reduced mRNA level of PDGF (Platelet-derived growth factor), α-SMA (α-smooth muscle actin) and TGF-β (transforming growth factor-β) than DMN-induced hepetic fibrosis animals in the liver tissue. In this study, we showed that HTHQ improves against DMN-induced liver fibrosis in male SD rats.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ahmed, A. and Keeffe, E.B. (2004). Chronic hepatitis C with normal aminotransferase levels. Gastroenterology, 126, 1409–1415.
Baskol, G., Atmaca, H., Tanriverdi, F., Baskol, M., Kocer, D. and Bayram, F. (2007). Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp. Clin. Endocrinol. Diabetes, 115, 522–526.
Bertelli, A.A., Giovannini, L., Stradi, R., Bertelli, A. and Tillement, I.P. (1996). Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4’,5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React, 18, 67–71.
Britton, R.S. and Bacon, B.R. (1994). Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology, 41, 343–348.
Cooksley, W.G., Bradbear, R.A., Robinson, W., Harrison, M., Halliday, J.W., Powell, L.W., Ng, H.S., Seah, C.S., Okuda, K., Scheuer, PJ. and Sherlock, S. (1986). The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology, 6, 345–348.
Edwards, C.K., 3rd, Myers, M.I., Kelley, K.W. and Schook, L.B. (1991). Enhanced macrophage anti-microbial activity following dimethylnitrosamine exposure in vivo is related to augmented production of reactive oxygen metabolites. Immunopharmacol. Immunotoxicol, 13, 395–411.
Elsharkawy, A.M., Wright, M.C., Hay, R.T., Arthur, M.l, Hughes, T., Bahr, M.J., Degitz, K. and Mann, D.A. (1999). Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins. Hepatology, 30, 761–769.
Farber, E. (1996). Orientation in Liver Toxicity by Drugs, Handbook of Experimental Pharmacology, Springer-Verlag, Berlin, Germany.
Friedman, S.L. (1990). Cellular sources of collagen and regulation of collagen production in liver. Semin. Liver Dis., 10, 20–29.
Friedman, S.L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 2247–2250.
Friedman, S.L., Roll, F.J., Boyles, I. and Bissell, D.M. (1985). Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. USA, 82, 8681–8685.
Gressner, A.M. and Bachern, M.G. (1990). Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fib-rogenesis. Semin. Liver Dis., 10, 30–46.
Haggerty, H.G and Holsapple, M.P. (1990). Role of metabolism in dimethylnitrosamine-induced immunosuppression: a review. Toxicology, 63, 1–23.
Hashimoto, N., Ishikawa, Y. and Utsunomiya, J. (1989). Effects of portacaval shunt, transposition, and dimethylnitrosamine-induced chronic liver injury on pancreatic hormones and amino acids in dog. J. Surg. Res., 46, 35–40.
Hirose, M., Akagi, K., Hasegawa, R., Yaono, M., Satoh, T., Hara, Y., Wakabayashi, K. and Ito, N. (1995a). Chemoprevention of 2-amino-l -methyl-6-phenylimidazo[4,5-b]-pyridine (PhlP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. Carcinogenesis, 16, 217–221.
Hirose, M., Hasegawa, R., Kimura, J., Akagi, K., Yoshida, Y., Tanaka, H., Miki, T., Satoh, T., Wakabayashi, K., Ito, N. and Shirai, T. (1995b). Inhibitory effects of l-0-hexyl-2,3,5-trime-thylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[l,2-a:3’,2’-d]imidazole (Glu-P-l)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-fJquinoxaline (MelQx). Carcinogenesis, 16, 3049–3055.
Hirose, M., Ito, T., Takahashi, S., Ozaki, M., Ogiso, T., Nihro, Y, Miki, T. and Shirai, T. (1998). Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo[4,5-fJquinoxa-line (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesis. Eur. J. Cancer Prev.,7, 233–241.
Hirose, M., Iwata, S., Ito, E., Nihro, Y., Takahashi, S., Mizoguchi, Y., Miki, T., Satoh, T., Ito, N. and Shirai, T. (1995c). Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-O-hexyl-2,3,5-trimethylhydroquinone against heterocyclic amine-induced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[l,2-a:3’,2’-d] imidazole (Glu-p-1). Carcinogenesis, 16, 2227–2232.
Jezequel, A.M., Mancini, R., Rinaldesi, M.L., Ballardini, G., Fallani, M., Bianchi, F. and Orlandi, F. (1989). Dimethylnitro-samine-induced cirrhosis. Evidence for an immunological mechanism. J. Hepatol, 8, 42–52.
Lang, A., Schoonhoven, R., Tuvia, S., Brenner, D.A. and Rippe, R.A. (2000). Nuclear factor kappaB in proliferation, activation, and apoptosis in rat hepatic stellate cells. J. Hepatol, 33, 49–58.
Li, B.L., Zhao, X.X., Liu, X.Y., Kim, H.S., Raska, K., Jr., Ortaldo, J.R., Schwartz, B. and Pestka, S. (1990). Alpha-interferon structure and natural killer cell stimulatory activity. Cancer Res., 50, 5328–5332.
Luckey, S.W. and Petersen, D.R. (2001). Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp. Mol Pathol, 71, 226–240.
Magee, P.N. and Barnes, J.M. (1967). Carcinogenic nitroso compounds. Adv. Cancer Res., 10, 163–246.
Mancuso, C., Pani, G. and Calabrese, V. (2006). Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep., 11, 207–213.
Marra, F., Gentium, A., Pinzani, M., Choudhury, G.G., Parola, M., Herbst, H., Dianzani, M.U., Laffi, G., Abboud, H.E. and Gentium, P. (1997). Phosphatidylinositol 3-kinase is required for platelet-derived growth factor’s actions on hepatic stellate cells. Gastroenterology, 112, 1297–1306.
Maton, A., Hopkins J., McLaughlin, C.W., Johnson, S., Warner, M.Q., LaHart, D. and Wright, J.D. (1993). Human Biology and Health. Englewood Cliffs, New Jersey, USA: Prentice Hall.
McGavin, M.D. and Zachary, J.F. (2007). Pathologic basis of veterinary disease, Elsevier Mosby, St.Louis.
Nihro, Y., Furukawa, H., Sogawa, S., Wang, T.C., Miyataka, H., Matsumoto, H., Miki, T. and Satoh, T. (1994). Synthesis and anti lipid-peroxidation activity of hydroquinone monoalkyl ethers. Chem. Pharm. Bull. (Tokyo), 42, 576–579.
Pinzani, M., Marra, F. and Carloni, V. (1998). Signal transduction in hepatic stellate cells. Liver, 18, 2–13.
Saile, B., Matthes, N., Knittel, T. and Ramadori, G. (1999). Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology, 30, 196–202.
Shiba, M., Shimizu, I., Yasuda, M., Ii, K. and Ito, S. (1998). Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver, 18, 196–204.
Shimizu, I., Mizobuchi, Y., Yasuda, M., Shiba, M., Ma, Y.R., Horie, T., Liu, F. and Ito, S. (1999). Inhibitory effect of oestra-diol on activation of rat hepatic stellate cells in vivo and in vitro. Gut, 44, 127–136.
Strain, A. and Anna, M.D. (1998). Liver Growth and Repair, Chapman & Hall, London.
Trump, B.F. and Berezesky, I.K. (1992). The role of cytosolic Ca2+ in cell injury, necrosis and apoptosis. Curr. Opin. Cell Biol., 4, 227–232.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jung, YR., Lee, YJ., Lee, NJ. et al. Inhibitory Effect of 1-O-Hexyl-2,3,5-Trimethylhydroquinone on Dimethylnitrosamine-induced Liver Fibrosis in Male SD Rats. Toxicol Res. 26, 193–201 (2010). https://doi.org/10.5487/TR.2010.26.3.193
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2010.26.3.193